Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TIGIT anticorps (AA 22-141)

TIGIT Reactivité: Humain ELISA, FACS, Coat, IHC (f) Hôte: Souris Monoclonal TIGIT-3017 unconjugated
N° du produit ABIN6938572
  • Antigène Voir toutes TIGIT Anticorps
    TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))
    Épitope
    • 10
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 22-141
    Reactivité
    • 23
    • 14
    • 1
    Humain
    Hôte
    • 19
    • 16
    • 1
    • 1
    Souris
    Clonalité
    • 20
    • 15
    • 2
    Monoclonal
    Conjugué
    • 23
    • 4
    • 4
    • 3
    • 2
    • 1
    Cet anticorp TIGIT est non-conjugé
    Application
    • 15
    • 14
    • 14
    • 11
    • 7
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Flow Cytometry (FACS), Coating (Coat), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Specificité
    TIGIT is a checkpoint inhibitor which binds with high affinity to the poliovirus receptor (PVR), causing increased IL10 secretion, decreased IL12B secretion. TIGIT binding to PVR also causes the suppression of T cell activation by promoting the generation of mature immuno-regulatory dendritic cells. It is expressed at low levels on natural killer (NK) cells, as well as peripheral memory and regulatory CD4+ T cells. At the protein level, it is upregulated following the activation of these cells. Functionally, TIGIT is similar to CTLA4. The ligands for TIGIT include CD155 (signal abrogation) and CD226 (signal stimulation). It has been demonstrated to be upregulated on T cells in many cancers and is an immuno-oncology target for therapy.
    Réactivité croisée (Details)
    Human.
    Purification
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogène
    Recombinant fragment (around aa 22-141) of human TIGIT protein (exact sequence is proprietary)
    Clone
    TIGIT-3017
    Isotype
    IgG2c kappa
    Top Product
    Discover our top product TIGIT Anticorps primaire
  • Indications d'application

    Known_Application: ELISA (For coating, order antibody without BSA), Flow Cytometry (1-2 μg/million cells),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: MOLT-4, Prostate or Colon Carcinoma.

    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Agent conservateur
    Azide free
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Date de péremption
    24 months
  • Antigène
    TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))
    Autre désignation
    TIGIT (TIGIT Produits)
    Synonymes
    anticorps VSIG9, anticorps VSTM3, anticorps WUCAM, anticorps ENSMUSG00000071552, anticorps Vstm3, anticorps RGD1563191, anticorps T-cell immunoreceptor with Ig and ITIM domains, anticorps T cell immunoreceptor with Ig and ITIM domains, anticorps TIGIT, anticorps Tigit
    Sujet
    T-cell immunoreceptor with Ig and ITIM domains, V-set and immunoglobulin domain containing 9 (VSIG9), V-set and transmembrane domain containing 3 (VSTM3), Washington University cell adhesion molecule (WUCAM),TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer)
    Cellular localisation: Cell Surface
    Poids moléculaire
    26kDa
    ID gène
    201633, 421750
    Pathways
    Cancer Immune Checkpoints
Vous êtes ici:
Support technique